CAS: 6972-82-3; 5,6-Diamino-1-Methyluracil

相似化合物

110475-23-5 172751-17-6 55441-70-8

上下游产品

CAS号6972-78-7 6-氨基-1-甲基-5-硝基尿嘧啶 | CAS号2434-53-9 6-氨基-1-甲基脲嘧啶 | CAS号54058-36-5 2,4(1H,3H)-Pyri... | CAS号605-99-2 3-甲基尿酸-d3 | CAS号14785-95-6 Formamide,N-(6-... | CAS号2850-34-2 3-methyl-8-phen... | CAS号83-67-0 可可碱 | CAS号1076-22-8 3-甲基黄嘌呤 | CAS号3659-97-0 1-Methyl-2,4,5-... | CAS号2565-47-1 1-甲基巴比妥酸 | CAS号58378-08-8 1,1'-dimethyl[5... | CAS号19845-24-0 2,4(1H,3H)-Pter... | CAS号27038-81-9 1H-Purine-2,6-d...

6-氨基-1-甲基尿嘧啶置于sodium Hydrogensulfite,溶剂黄146,Sodium Nitrite体系中,用 水 作为反应溶剂,化学反应 5.0H,反应生成 5,6-二氨基-1-甲基尿嘧啶
参考文献:Easy Preparative Scale Syntheses Of Labelled Xanthines: Caffeine,Theophylline And Theobromine
标题:Easy Preparative Scale Syntheses Of Labelled Xanthines: Caffeine,Theophylline And Theobromine
摘要:描述了几种易于准备的规模(0.5-1.5克)氘标记咖啡因,可可碱和茶碱的合成方法.开发了一些新的选择性合成可可碱和茶碱的方法.标记的黄嘌呤在定性或定量同位素稀释质谱中具有很大兴趣,并与气相色谱或液相色谱结合,目前在反兴奋剂和法医实验室中进行.版权 © 2007 John Wiley & Sons,Ltd.
DOI:10.1002/jlcr.1154

专利信息

专利号:US-7521554-B2
优先权日:2001-11-09
标题 :A2B adenosine receptor antagonists
发明人：ELZEIN ELFATIH; KALLA RAO; MARQUART TIM; ZABLOCKI JEFF; LI XIAOFEN
权利人:CV THERAPEUTICS INC
摘要:Disclosed are processes for the synthesis of novel compounds that are A 2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.